Thank you for your comments.
We attempted to address the question of late tube dependence, but as you have also found, there is little published data in this area that sufficiently addresses this phenomena, particularly in relation to level of rehabilitation provided to the patient by the allied health team. See further details on this in Q25.
Prophylactic gastrostomy is recommended for certain groups in Q15. We probably need to make this clearer to mean concurrent chemoradiotherapy. With regards to induction chemotherapy, there is again little evidence specifically in this area, and so in Q20 we suggest discussion with the team for the best form of nutritional support depending on the anticipated side effects.
Teresa Brown, on behalf of the authors